BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea
· Delayed Price · Currency is KRW 14,820
+10 (0.07%)
Last updated: May 12, 2025
BIO-FD&C Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Operating Revenue | 16,066 | 15,592 | 15,855 | 11,972 | 8,640 | Upgrade
|
| Other Revenue | -0 | -0 | - | -0 | - | Upgrade
|
| Revenue | 16,066 | 15,592 | 15,855 | 11,972 | 8,640 | Upgrade
|
| Revenue Growth (YoY) | 3.04% | -1.66% | 32.44% | 38.57% | 1.93% | Upgrade
|
| Cost of Revenue | 4,852 | 4,563 | 4,908 | 4,895 | 3,032 | Upgrade
|
| Gross Profit | 11,214 | 11,029 | 10,948 | 7,077 | 5,608 | Upgrade
|
| Selling, General & Admin | 4,369 | 4,283 | 4,418 | 2,883 | 1,682 | Upgrade
|
| Research & Development | 1,699 | 1,429 | 1,449 | 815.9 | 738.83 | Upgrade
|
| Other Operating Expenses | - | - | 89.25 | 48.93 | 40.58 | Upgrade
|
| Operating Expenses | 6,362 | 5,995 | 6,067 | 3,939 | 2,683 | Upgrade
|
| Operating Income | 4,853 | 5,034 | 4,881 | 3,138 | 2,925 | Upgrade
|
| Interest Expense | -63.47 | -127.82 | -108.93 | -62.29 | -69.67 | Upgrade
|
| Interest & Investment Income | 1,334 | 1,098 | 564.04 | 30.95 | 56.22 | Upgrade
|
| Currency Exchange Gain (Loss) | 238.13 | 2.09 | 130.71 | 133.49 | -90.4 | Upgrade
|
| Other Non Operating Income (Expenses) | -26.73 | -25.13 | -19.47 | 44.7 | 57.97 | Upgrade
|
| EBT Excluding Unusual Items | 6,334 | 5,981 | 5,447 | 3,284 | 2,879 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1,106 | 1,170 | -3.63 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.19 | 0.43 | - | 8.88 | 2.54 | Upgrade
|
| Pretax Income | 5,228 | 7,152 | 5,443 | 3,293 | 2,881 | Upgrade
|
| Income Tax Expense | 726.69 | 1,567 | 1,108 | 385.7 | 419.98 | Upgrade
|
| Net Income | 4,501 | 5,585 | 4,335 | 2,908 | 2,461 | Upgrade
|
| Net Income to Common | 4,501 | 5,585 | 4,335 | 2,908 | 2,461 | Upgrade
|
| Net Income Growth | -19.41% | 28.83% | 49.10% | 18.13% | -3.92% | Upgrade
|
| Shares Outstanding (Basic) | 9 | 9 | 9 | 7 | 7 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 9 | 9 | 7 | 7 | Upgrade
|
| Shares Change (YoY) | -0.03% | -3.16% | 19.02% | 0.39% | 0.11% | Upgrade
|
| EPS (Basic) | 528.00 | 655.00 | 492.33 | 394.00 | 334.00 | Upgrade
|
| EPS (Diluted) | 528.00 | 655.00 | 492.33 | 393.00 | 334.00 | Upgrade
|
| EPS Growth | -19.39% | 33.04% | 25.27% | 17.66% | -4.02% | Upgrade
|
| Free Cash Flow | 4,779 | 4,057 | 5,421 | -3,330 | 242.92 | Upgrade
|
| Free Cash Flow Per Share | 560.57 | 475.82 | 615.60 | -450.12 | 32.96 | Upgrade
|
| Gross Margin | 69.80% | 70.74% | 69.05% | 59.11% | 64.91% | Upgrade
|
| Operating Margin | 30.20% | 32.29% | 30.78% | 26.21% | 33.85% | Upgrade
|
| Profit Margin | 28.01% | 35.82% | 27.34% | 24.29% | 28.49% | Upgrade
|
| Free Cash Flow Margin | 29.74% | 26.02% | 34.19% | -27.82% | 2.81% | Upgrade
|
| EBITDA | 6,066 | 6,121 | 5,930 | 3,764 | 3,529 | Upgrade
|
| EBITDA Margin | 37.75% | 39.26% | 37.40% | 31.44% | 40.84% | Upgrade
|
| D&A For EBITDA | 1,213 | 1,087 | 1,049 | 626.04 | 603.95 | Upgrade
|
| EBIT | 4,853 | 5,034 | 4,881 | 3,138 | 2,925 | Upgrade
|
| EBIT Margin | 30.20% | 32.29% | 30.78% | 26.21% | 33.85% | Upgrade
|
| Effective Tax Rate | 13.90% | 21.91% | 20.36% | 11.71% | 14.58% | Upgrade
|
| Advertising Expenses | - | - | - | 11.56 | 70.13 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.